Smith & Nephew Plc Director/PDMR Shareholding
24 Mai 2024 - 5:37PM
RNS Regulatory News
RNS Number : 9151P
Smith & Nephew Plc
24 May 2024
SMITH & NEPHEW PLC
24 May 2024
NOTIFICATION AND PUBLIC DISCLOSURE
IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE
REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH
THEM.
|
Reason for the notification
|
|
Initial notification
/Amendment
|
Initial notification
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
|
LEI
|
213800ZTMDN8S67S1H61
|
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith &
Nephew plc ordinary shares of USD 0.20 each
|
|
Identification code
|
ISIN: GB0009223206
|
|
Nature of the transaction
|
Purchase of ordinary shares through
the Company's Dividend Re-Investment Plan following the 2023 final
dividend payment on 22 May 2024.
|
|
Date of Transaction
|
2024 - 05 - 22
|
|
Place of Transaction
|
London Stock Exchange
(XLON)
|
|
Name
(Position)
|
Director / PDMR
|
Price
|
Volume
|
Aggregated information
|
|
Helen Barraclough
(Group General Counsel and Company
Secretary)
|
PDMR
|
10.1921
|
627.51301
|
N/A Single Transaction
|
|
Craig Gaffin
(President, Global
Orthopaedics)
|
PDMR
|
10.1921
|
132.42844
|
N/A Single Transaction
|
|
Paul Connolly
(President, Global
Operations)
|
PDMR
|
10.1921
|
290.35933
|
N/A Single Transaction
|
|
Phil Cowdy
Chief Corporate Development &
Corporate Affairs Officer
|
PDMR
|
10.1921
|
158.47807
|
N/A Single Transaction
|
|
Mizanu Kebede
(Chief Quality & Regulatory
Affairs Officer)
|
PDMR
|
10.1921
|
166.31452
|
N/A Single Transaction
|
|
Deepak Nath
(Chief Executive Officer)
|
Director
|
10.1921
|
2,866.48338
|
N/A Single Transaction
|
|
Alison Parkes
(Chief Compliance
Officer)
|
PDMR
|
10.1921
|
78.39762
|
N/A Single Transaction
|
|
Scott Schaffner
(President, Sports
Medicine)
|
PDMR
|
10.1921
|
1,168.88629
|
N/A Single Transaction
|
|
Vasant Padmanabhan
(President Research &
Development and ENT)
|
PDMR
|
10.1921
|
196.76528
|
N/A Single Transaction
|
Sarah Carne
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923
477100
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHFLFVEESISFIS
Smith & Nephew (LSE:SN.)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Smith & Nephew (LSE:SN.)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
